JVMAX
Price
$23.97
Change
-$1.42 (-5.59%)
Updated
Apr 3 closing price
Net Assets
21.35B
SMVTX
Price
$10.79
Change
-$0.83 (-7.14%)
Updated
Apr 3 closing price
Net Assets
1.53B
Ad is loading...

JVMAX vs SMVTX

Header iconJVMAX vs SMVTX Comparison
Open Charts JVMAX vs SMVTXBanner chart's image
JHancock Disciplined Value Mid Cap A
Price$23.97
Change-$1.42 (-5.59%)
VolumeN/A
Net Assets21.35B
Virtus Ceredex Mid-Cap Value Equity I
Price$10.79
Change-$0.83 (-7.14%)
VolumeN/A
Net Assets1.53B
JVMAX vs SMVTX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JVMAX vs. SMVTX commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JVMAX is a Buy and SMVTX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
JVMAX has more cash in the bank: 21.4B vs. SMVTX (1.54B). SMVTX pays higher dividends than JVMAX: SMVTX (1.07) vs JVMAX (0.61). JVMAX was incepted earlier than SMVTX: JVMAX (28 years) vs SMVTX (23 years). JVMAX (1.13) is less costly to investors than SMVTX (1.02). SMVTX is a more actively managed with annual turnover of: 140.00 vs. JVMAX (47.00). JVMAX has a lower initial minimum investment than SMVTX: JVMAX (1000) vs SMVTX (100000). SMVTX annual gain was more profitable for investors over the last year : -7.59 vs. JVMAX (-8.70). JVMAX return over 5 years is better than : 86.30 vs. SMVTX (52.60).
JVMAXSMVTXJVMAX / SMVTX
Total Expense Ratio1.121.02110%
Annual Report Gross Expense Ratio1.131.02111%
Fund Existence28 years23 years-
Gain YTD-0.118-3.1674%
Front Load5%N/A-
Min. Initial Investment10001000001%
Min. Initial Investment IRAN/AN/A-
Net Assets21.4B1.54B1,394%
Annual Yield % from dividends0.611.0757%
Returns for 1 year-8.70-7.59115%
Returns for 3 years-2.01-5.0839%
Returns for 5 years86.3052.60164%
Returns for 10 years28.82-8.43-342%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ABEO4.950.27
+5.77%
Abeona Therapeutics
OCX2.92-0.03
-1.02%
Oncocyte Corp
VICI31.66-0.53
-1.65%
VICI Properties
FOUR79.29-6.53
-7.61%
Shift4 Payments
MRC10.56-1.13
-9.67%
MRC Global